# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst Daniel Stauder reiterates Avanos Medical (NYSE:AVNS) with a Market Perform.
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.21 ...
The Nurse Assist voluntary recall was initiated due to concerns about the potential lack of sterility assurance in these water-...
Avanos Medical (NYSE:AVNS) reported quarterly earnings of $0.36 per share which missed the analyst consensus estimate of $0.37 ...
2024 Outlook The Company expects 2024 net sales to be between $685 and $705 million, which assumes organic growth between 3% t...
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue...
Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...
Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and fu...